• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The Enduring Health Challenges of Afghan Immigrants and Refugees in Iran: A Systematic Review
This article does not contain any studies with human participants or animals performed by the author. Data Availability All national (MagIran, Science Information Database (SID) and Iranmedex) and international (PubMed, Scopus) databases were searched from November 2010 to November 2016 using keywords both in English and Persian: Afghan immigrants, Afghan refugees, Iran, infectious diseases, tuberculosis, HIV, Hepatitis B and C, non-communicable disease, food security, mental health, barriers, health insurance, access to health service. All related websites and webpages were also searched by Google with the same keywords ...
Source: PLOS Currents Disasters - July 21, 2017 Category: International Medicine & Public Health Authors: nasim Source Type: research

MassDevice.com +5 | The top 5 medtech stories for August 18, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Study: New infrared imaging technique could help detect heart attack, stroke risk A new near-infrared diagnostic technique could help improve early detection for patients at risk of heart attacks or strokes, according to a new ...
Source: Mass Device - August 18, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Cheetah Medical raises $12m
Cheetah Medical said today it raised $11.8 million in an expanded Series C funding round as it looks to grow its US footprint. Financing was provided by existing investors including MVM Life Science Partners, Springfield Investment Management, Fletcher Spaght Ventures, HighCape Partners and Robert Basch Venture Capital, the Newton, Mass.-based company said. Cheetah Medical provides noninvasive hemodynamic monitoring devices and systems, including its Cheetah Nicom and Starlin SV technologies, which operate around a proprietary algorithm designed to allow physicians to examine a patient’s full hemodynamic profile. &#...
Source: Mass Device - September 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cheetah Medical Source Type: news

Device that measures cell strength could help identify drugs for asthma, hypertension and muscular dystrophy
Engineers, doctors and scientists at UCLA and Rutgers University have developed a tool that measures the physical strength of individual cells 100 times faster than current technologies.The new device could make it easier and faster to test and evaluate new drugs for diseases associated with abnormal levels of cell strength, including hypertension, asthma and muscular dystrophy. It could also open new avenues for biological research into cell force. It is the first high-throughput tool that can measure the strength of thousands of individual cells at a time.“Our tool tracks how much force individual cells exert over time...
Source: UCLA Newsroom: Health Sciences - February 9, 2018 Category: Universities & Medical Training Source Type: news

Finding Good Candidates for Risk-Sharing Arrangements
Continued from Part I that discusses the tools device manufacturers can use to manage risk How to find good candidates? Not all devices are created equal. But how can device manufacturers identify the low-hanging fruit for a risk-sharing arrangement? Needless to say, the more characteristics a product has that are associated with successful risk-sharing arrangements, the more such an arrangement is likely to succeed. To illustrate, in Exhibit 1, we chart a select number of risk-sharing arrangements established since 2015 along two key dimensions: product effectiveness and time needed to observe expected outcomes. The findi...
Source: MDDI - April 3, 2018 Category: Medical Devices Authors: Harry Liu and Christine Chen Tags: Contract Manufacturing Design Source Type: news

5 Trends Medtech Should Be Talking About
Recently I chatted with Candace Roulo, managing editor of Advanced Manufacturing Now, about some of the most important trends in medtech and the technologies that are taking the industry to the next level. Click below to listen to the podcast, or read on for select highlights of the conversation – what I consider to be five trends medtech professionals should be talking about. 128-Advanced_Manufacturing_Now-UBM.mp3 Explore all of these trends in depth at the BIOMEDevice Boston Conference and Expo, April 18-19, 2018. Use promo code "SAVE100" for $100 off conference registration and free expo access.   1. Muc...
Source: MDDI - April 6, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: BIOMEDevice Boston Business Digital Health Source Type: news

Medtronic touts data from Micra pacer AV algorithm study
Medtronic (NYSE:MDT) late last week released data from a new clinical study of an algorithm used with its Micra transcatheter pacing system, touting that it has the potential to restore atrioventricular synchrony and improve cardiac function in patients with sinus rhythm and AV block. Results from the study were presented at the Heart Rhythm Society’s annual scientific sessions in Boston, the Fridley, Minn.-based company said. Researchers in the Marvel study examined the use of the algorithm, which uses the Mira pacer’s accelerometer signal, in 64 patients, Medtronic said. Investigators aimed to evaluate whether ...
Source: Mass Device - May 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Clinical Trials Medtronic Source Type: news

NA Looks to Lead Robotics-Based Ultrasound Revolution
Neural Analytics is bringing robotics to the world of ultrasound through its NeuralBot system. The Los Angeles, CA-based company said it has both CE mark and FDA clearance for the technology, which is an ultrasound guidance device to observe blood flow to the brain. The firm said NeuralBot will be launched in both Europe and the U.S. throughout the course of next year. “We have identified a number of clinical partners and sites that are excited to be early adopters of the system,” Loe Petrossian, PhD and CEO of Neural Analytics, told MD+DI. Petrossian helped found the Neural Analytics in 2013. The private company has r...
Source: MDDI - June 19, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Contract manufacturer Minnetronix has a new med-tech customer: itself
Minnetronix, a 22-year-old medical technology business based in St. Paul, has long specialized as a contract manufacturer — building med-tech devices designed by other firms. It's now growing beyond that role with a new product developed in-house. The Star Tribune reports on the milestone at Minnetronix, which is working on a device Neurapheresis Therapy that is designed to decontaminate cerebrospinal fluid after a hemorrhagic stroke. The brain needs that fluid clean to function, but the bleeding…
Source: bizjournals.com Health Care:Biotechnology headlines - September 10, 2018 Category: Biotechnology Authors: Mark Reilly Source Type: news

Temperature constrains locomotion and muscle function in two temperate labrids
This study highlights the physiological stress temperature places on locomotor musculature and its consequences on whole organism locomotion. Cunner and tautog experience temperatures ranging from 0 to 25 °C and enter dormancy at ~10 °C. We aimed to address the question: how do winter temperatures affect steady swimming and muscle contraction kinetics in cunner? Fishes were collected and housed at 5, 10, 15, or 20 °C. Gait transition speed and fin beat frequency were measured at each acclimation temperature. Twitch and tetanus kinetics were recorded from the aerobic locomotor muscle, which is responsible for the p...
Source: Comparative Biochemistry and Physiology Part A: Molecular and Integrative Physiology - October 21, 2018 Category: Biochemistry Source Type: research

Temperature constrains locomotion and muscle function in two temperate labrids.
This study highlights the physiological stress temperature places on locomotor musculature and its consequences on whole organism locomotion. Cunner and tautog experience temperatures ranging from 0 to 25 °C and enter dormancy at ~10 °C. We aimed to address the question: how do winter temperatures affect steady swimming and muscle contraction kinetics in cunner? Fishes were collected and housed at 5, 10, 15, or 20 °C. Gait transition speed and fin beat frequency were measured at each acclimation temperature. Twitch and tetanus kinetics were recorded from the aerobic locomotor muscle, which is responsible for the p...
Source: Comparative Biochemistry and Physiology. Part A, Molecular and integrative physiology. - October 19, 2018 Category: Physiology Authors: Moran CJ, Neubauer DL, Rzucidlo CL, Gerry SP Tags: Comp Biochem Physiol A Mol Integr Physiol Source Type: research

Fibrinolysis of Contracted Blood Clots Depends on Whether Plasminogen Activator Acts from inside or Outside
Fibrinolysis involves the dissolution of polymeric fibrin networks that is required to restore blood flow through vessels obstructed by clots and thrombi. The efficiency of lysis depends on the susceptibility of fibrin to enzymatic digestion, which is governed by the structure and spatial organization of fibrin fibers as well as porosity and composition of the clot. Platelet-driven clot contraction results in compaction of the erythrocytes into the core of the clot, effectively reducing the permeability of the clot, and influences fibrin network structure. We have shown that clot contraction is reduced in blood from patien...
Source: Blood - November 21, 2018 Category: Hematology Authors: Tutwiler, V., Peshkova, A. D., Le Minh, G., Zaitsev, S., Litvinov, R. I., Cines, D. B., Weisel, J. W. Tags: 321. Blood Coagulation and Fibrinolytic Factors: Poster III Source Type: research

The new GP contract: transforming primary care, transforming CVD prevention
NHS England ’s National Clinical Director for Cardiovascular Disease Prevention and the Chief Executive of the British Heart Foundation share their thoughts on the new GP contract and the positive impact that the changes could have on the outcomes and quality of life for people across the country Related items fromOnMedica Invest in GP services to improve heart failure survival Statins cut risk of strokes/heart attacks irrespective of patient ’s age Ending the postcode lottery of stroke care Hypertension: what ’s new and how might this impact practice? Know your heart health risk stats as well as your PIN number, public urged
Source: OnMedica Views - February 25, 2019 Category: Primary Care Source Type: news

Patients with atrial fibrillation to be targeted in stroke reduction programme
Programme will identify and treat patients with atrial fibrillation not receiving adequate preventive care Related items fromOnMedica The new GP contract: transforming primary care, transforming CVD prevention Fund specialist dementia training to improve care and save money Brexit could result in thousands of extra CVD deaths Risk of CV event highest straight after partner death Millions miss out on vital diabetes health checks
Source: OnMedica Latest News - May 6, 2019 Category: UK Health Source Type: news

Achieving GP diabetes targets could boost health and cut costs
Possible 30 years life gain per 100 patients and £727m savings Related items fromOnMedica CCGs must focus more on foot care Shocking variation in diabetes care across UK Coronary heart disease remains UK ’s biggest killer The new GP contract: transforming primary care, transforming CVD prevention Dementia and stroke funding remains too low, say experts
Source: OnMedica Latest News - August 11, 2019 Category: UK Health Source Type: news

Pages: 1  2  3  4  5  6  7  8